Dacomitinib for Treatment of Patients in India With Metastatic Non Small Cell Lung Cancer With EGFR Activating Mutations

NCT04511533 · clinicaltrials.gov ↗
PHASE4
Phase
COMPLETED
Status
101
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Pfizer